Related Experiment Videos
[Tumor markers in bronchus cancer]
1Universitätsklinik für Innere Medizin, Innsbruck.
Wiener Klinische Wochenschrift
|July 14, 1989
Summary
Neuron specific enolase (NSE) is the best tumor marker for small cell lung cancer, detected in 65-85% of patients. Tumor marker levels correlate with disease stage and can indicate recurrence or progression.
Area of Science:
- Oncology
- Biochemistry
- Medical Diagnostics
Context:
- Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are major forms of lung malignancy.
- Neuroendocrine tumors, including SCLC, produce various peptide hormones and neuropeptides.
- Accurate tumor markers are crucial for diagnosis, staging, and monitoring treatment response.
Purpose:
- To review the utility of various biomarkers in small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
- To highlight neuron specific enolase (NSE) as a primary marker for SCLC.
- To discuss the role of tumor markers in assessing disease progression and recurrence.
Summary:
- Small cell lung cancers, being neuroendocrine tumors, express markers like chromogranin A, calcitonin, ACTH, and ADH.
- Neuron specific enolase (NSE) is identified as the most effective marker for SCLC, with elevated levels in 65-85% of patients.
- Tumor marker levels correlate with tumor stage and treatment response, with rising levels indicating progression or recurrence. CEA is noted as valuable for NSCLC.
Impact:
- Establishes NSE as a key diagnostic and monitoring tool for SCLC.
- Provides insights into the clinical significance of tumor markers in lung cancer management.
- Suggests potential for early detection of recurrence and central nervous system metastases through marker monitoring.